Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.
about
DNA adducts in humans as biomarkers of exposure to environmental and occupational carcinogensCuring metastatic testicular cancerThe treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP)Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to CollaborationEtiology and early pathogenesis of malignant testicular germ cell tumors: towards possibilities for preinvasive diagnosisA note from history: Landmarks in history of cancer, part 7.Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group study.Cisplatin, vinblastine, and bleomycin combination therapy in resistant gestational trophoblastic disease.Early-onset thrombocytopenia during combination chemotherapy in testicular cancer is induced by vinblastine.VP-16-213 salvage therapy for refractory germinal neoplasms.A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 days.Cisplatin, bleomycin, and vinblastine combination therapy of testicular tumors: an analysis.Management of good risk germ-cell tumours.Complications of retroperitoneal lymph node dissection in testicular cancer: primary and post-chemotherapy.Regular review: Managing testicular cancerOutcomes for children and adolescents with cancer: challenges for the twenty-first century.Use of an automated capillary DNA sequencer to investigate the interaction of cisplatin with telomeric DNA sequences.An A,B,C,D of cancer chemotherapy.Possible structural role of the disaccharide unit in Fe-bleomycin before and after oxygen activation.Implications of successful combination chemotherapy for testicular germ cell neoplasms.Curing metastatic cancer: lessons from testicular germ-cell tumours.Solution structure of Fe(II)-azide-bleomycin derived from NMR data: transition from Fe(II)-bleomycin to Fe(II)-azide-bleomycin as derived from NMR data and structural calculations.Rare cancers and specialist centres.Mortality in patients with testicular cancer: report of the Anglia and Trent testicular tumour groupsEtiologic factors in testicular germ-cell tumorsQuantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy.Cancer chemotherapy: new strategies for success.Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care.Testicular cancers occurring in brothers with cryptorchism.Combination antiemetics for cisplatin chemotherapy.Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries.Rates of death from testicular cancer in Ontario in 1964-82: analysis by major histologic subgroups.Current status of retroperitoneal lymph node dissection and testicular cancer: when to operate.Intensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer.Testicular cancer. Role of primary care physicians in screening and education.Treatment of childhood germ cell tumors. Review of the St. Jude experience from 1979 to 1988.Yolk sac tumor of vagina: a case reportLaboratory markers and germ cell tumors.High-dose chemotherapy and stem cell transplantation for advanced testicular cancerIncreased stomach cancer risk following radiotherapy for testicular cancer
P2860
Q23920037-BD4DD8DB-D860-4DF1-9CFA-8D74FAB1B0D3Q24536158-DA2C34BD-9A1C-44DE-8F69-100108B09349Q24564931-F4BCBA14-4EF0-4F16-A1AF-8A62A4D65B58Q26797518-A31AFA78-EA36-41D1-BF7B-D3FCC92E3E2FQ26991452-D3A729EE-AF12-4255-90CE-2F5573887E5BQ30931923-C67C7006-934A-4404-A8F1-D6D94EDD1C47Q33367096-453C7392-D216-404B-A8BB-894FD7108124Q33411720-848B3380-D37D-449F-AB8A-6198C173F736Q33413955-B59ED77C-F07A-4765-91E1-88453062A9D4Q33475878-5E108988-5C04-49E6-BF9E-4A3A2DBA3A94Q33494306-10B957A0-8FFB-4ED8-913D-69C1B57D39E4Q33497993-59A526F8-BE7B-4B74-8BA9-05CF1FAB64F1Q33511330-F807A728-0C92-4344-969D-5E5745DAA9C0Q33788914-4C29FE05-58B1-4075-A759-E586087D7164Q33806081-8893E6B2-B4F1-4D1B-9364-C956568B60B0Q33897659-D92B0CEA-D0E3-469A-AFD7-7CEECB312437Q33934215-DB81695B-2E04-4A9D-A9B8-736215AD8EB2Q34052652-12294C16-CC7C-4DC2-940C-FE3F4770F77AQ34070201-2E9461B6-95E3-427D-ADFB-29ACEF2E0B74Q34107254-D3697335-919F-4277-A304-8C1FE722D4D5Q34210198-5C47EF98-63AB-4FC3-8216-A3B26B93A3CEQ34223506-3D258B7F-9A34-49B3-847B-55959F55382BQ34284243-7F52CAF1-BB30-45D7-AD54-66030B8A6D66Q34284369-A48BB144-6BDE-4A59-A5D7-91A862EAF119Q34396787-4B897733-4191-4B89-A220-9CBF49454E45Q34521285-B3051B72-D2EF-48A8-AD4B-848439E3D5E5Q34545133-2F51EACE-3467-4558-AD33-8D6F51F0C394Q34589066-09E0F071-34FC-4987-88B7-5E47D0E7449BQ34612237-C777631F-1ECF-4F9E-A118-D838CDA4527BQ34686969-C20910DC-FF95-4FBE-87F7-8F81DB0BB8BEQ34690717-1598D7AA-42A5-48D7-BA80-64B34768C1D5Q34728891-CA8D078B-B106-46C4-8501-2F89EBC4D98AQ34849119-A997D79F-2E09-48A5-8ED2-C6647E2C4B30Q34886445-D3AF3E5B-B0E3-4FD1-926C-9E6031AAC611Q35324654-7B6FD209-E6F4-4262-9132-89F3D9872B2FQ35344233-C5558470-EBFB-4A66-9A26-D4E64A246829Q35407104-5EB5389D-4A10-41D0-BB71-E5E1BBA79255Q35569729-98DD5BD7-3CC9-4B0A-BEC8-664DDC889921Q35660641-3D3F0E92-1E95-468E-992D-A7BA3F628D46Q35677701-2A872539-7B9F-48E9-A621-F8139ED210A1
P2860
Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh
1977年學術文章
@zh-hant
name
Cis-diamminedichloroplatinum, ...... isseminated testicular cancer.
@en
Cis-diamminedichloroplatinum, ...... isseminated testicular cancer.
@nl
type
label
Cis-diamminedichloroplatinum, ...... isseminated testicular cancer.
@en
Cis-diamminedichloroplatinum, ...... isseminated testicular cancer.
@nl
prefLabel
Cis-diamminedichloroplatinum, ...... isseminated testicular cancer.
@en
Cis-diamminedichloroplatinum, ...... isseminated testicular cancer.
@nl
P1476
Cis-diamminedichloroplatinum, ...... isseminated testicular cancer.
@en
P2093
P304
P356
10.7326/0003-4819-87-3-293
P407
P577
1977-09-01T00:00:00Z